Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3903 | RLYB Rallybio Corporation - Common Stock | 16.99 USD | +0.35% | +1.19% | +1.13% | +2989.09% | 90.23 M USD | ||
| 3904 | NMRA Neumora Therapeutics, Inc. - Common Stock | 0.48 USD | +2.13% | -14.29% | -60.00% | -74.87% | 90.19 M USD | ||
| 3907 | CLLS Cellectis S.A. - American Depositary Shares | 1.25 USD | -6.72% | -13.79% | -59.55% | -70.24% | 89.69 M USD | ||
| 3908 | PYPD PolyPid Ltd. - Ordinary Shares | 4.90 USD | -1.01% | -10.75% | -5.77% | +49.39% | 89.20 M USD | ||
| 3912 | ICCC ImmuCell Corporation - Common Stock | 9.75 USD | +0.62% | +1.35% | -0.91% | +42.96% | 88.55 M USD | ||
| 3914 | MIST Milestone Pharmaceuticals Inc. - Common Shares | 0.71 USD | -6.58% | -13.41% | -33.02% | -66.19% | 88.39 M USD | ||
| 3926 | CGTX Cognition Therapeutics, Inc. - Common Stock | 0.90 USD | -4.26% | -2.17% | -9.09% | -55.00% | 85.58 M USD | ||
| 3927 | NRXS Neuraxis, Inc. Common Stock | 6.80 USD | -0.58% | -6.21% | +17.24% | +25.23% | 85.39 M USD | ||
| 3940 | CRDF Cardiff Oncology, Inc. - Common Stock | 1.06 USD | -2.75% | -12.40% | +0.95% | -55.46% | 82.46 M USD | ||
| 3945 | PMN ProMIS Neurosciences Inc. - Common Shares | 9.15 USD | +0.33% | -3.38% | -33.16% | +1659.62% | 82.05 M USD | ||
| 3959 | ACRV Acrivon Therapeutics, Inc. - Common Stock | 1.87 USD | -0.53% | -8.78% | -7.88% | -5.08% | 80.14 M USD | ||
| 3964 | PMVP PMV Pharmaceuticals, Inc. - Common Stock | 1.49 USD | -0.67% | -14.86% | +8.76% | +7.97% | 79.65 M USD | ||
| 3968 | TELO Telomir Pharmaceuticals, Inc. - Common Stock | 1.15 USD | +2.68% | -1.71% | -3.36% | -35.75% | 79.09 M USD | ||
| 3980 | MNOV MediciNova, Inc. - Common Stock | 1.54 USD | -4.35% | -8.88% | -12.99% | +25.20% | 75.80 M USD | ||
| 3997 | NTRB Nutriband Inc. - Common Stock | 6.05 USD | -10.50% | -18.90% | -1.63% | -14.79% | 73.54 M USD | ||
| 4002 | OKYO OKYO Pharma Limited - American Depositary Shares | 1.39 USD | -2.80% | +4.51% | -0.71% | -34.43% | 72.95 M USD | ||
| 4017 | VRCA Verrica Pharmaceuticals Inc. - Common Stock | 4.18 USD | +0.97% | -13.64% | -21.13% | -30.56% | 71.81 M USD | ||
| 4020 | CING Cingulate Inc. - Common Stock | 4.88 USD | +0.21% | +1.88% | -6.87% | -20.78% | 70.96 M USD | ||
| 4023 | GANX Gain Therapeutics, Inc. - Common Stock | 1.62 USD | -2.99% | -7.43% | -5.81% | -23.58% | 70.70 M USD | ||
| 4025 | MAIA MAIA Biotechnology, Inc. Common Stock | 1.16 USD | 0.00% | -4.13% | -14.71% | -44.23% | 70.56 M USD |
Notícias Biotechnology Stocks
Estudo da Lancet mostra alívio mais rápido com remédio da Pharvaris para AEH
Raymond James inicia cobertura da Kymera Therapeutics com recomendação acima da média
Raymond James inicia cobertura da Nektar com classificação de desempenho de mercado
Ação da Palisade Bio inicia cobertura com Outperform na Raymond James
Raymond James mantém recomendação para ações da Liquidia em meio a processos judiciais
Ginkgo Bioworks vai apoiar o programa NSF X-Labs com acesso a laboratório
AbCellera apresentará dados de fase 1/2 sobre candidato a medicamento para menopausa
Gainers Biotechnology Stocks
GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |